These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7674836)
1. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. Suzuki H; Noda Y; Paul S; Gao XP; Rubinstein I Life Sci; 1995; 57(15):1451-7. PubMed ID: 7674836 [TBL] [Abstract][Full Text] [Related]
2. Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ. Suzuki H; Noda Y; Gao XP; Séjourné F; Alkan-Onyuksel H; Paul S; Rubinstein I Am J Physiol; 1996 Jul; 271(1 Pt 2):H282-7. PubMed ID: 8760186 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo. Séjourné F; Suzuki H; Alkan-Onyüksel H; Gao XP; Ikezaki H; Rubinstein I Am J Physiol; 1997 Jul; 273(1 Pt 2):R287-92. PubMed ID: 9249562 [TBL] [Abstract][Full Text] [Related]
4. Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. Ikezaki H; Paul S; Alkan-Onyüksel H; Patel M; Gao XP; Rubinstein I Am J Physiol; 1998 Jul; 275(1):R56-62. PubMed ID: 9688960 [TBL] [Abstract][Full Text] [Related]
5. All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo. Rubinstein I; Ashok B; Tsueshita T; Onyüksel H Peptides; 2005 Mar; 26(3):509-15. PubMed ID: 15652658 [TBL] [Abstract][Full Text] [Related]
6. Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo. Ikezaki H; Patel M; Onyüksel H; Akhter SR; Gao XP; Rubinstein I Am J Physiol; 1999 May; 276(5):R1359-65. PubMed ID: 10233028 [TBL] [Abstract][Full Text] [Related]
7. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Tsueshita T; Onyükusel H; Sethi V; Gandhi S; Rubinstein I Peptides; 2004 Jan; 25(1):65-9. PubMed ID: 15003357 [TBL] [Abstract][Full Text] [Related]
8. Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin. Rubinstein I; Patel M; Ikezaki H; Dagar S; Onyüksel H Peptides; 1999 Dec; 20(12):1497-501. PubMed ID: 10698126 [TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ. Suzuki H; Gao XP; Olopade CO; Rubinstein I Am J Physiol; 1996 Aug; 271(2 Pt 2):R393-7. PubMed ID: 8770140 [TBL] [Abstract][Full Text] [Related]
10. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity. Onyüksel H; Ashok B; Dagar S; Sethi V; Rubinstein I Peptides; 2003 Feb; 24(2):281-6. PubMed ID: 12668213 [TBL] [Abstract][Full Text] [Related]
11. Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo. Ikezaki H; Onyüksel H; Rubinstein I Am J Physiol; 1998 Aug; 275(2):R588-95. PubMed ID: 9688697 [TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. Gao XP; Noda Y; Rubinstein I; Paul S Life Sci; 1994; 54(15):PL247-52. PubMed ID: 8152324 [TBL] [Abstract][Full Text] [Related]
13. PGH(2)-TxA(2)-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension. Suzuki H; Ikezaki H; Hong D; Rubinstein I J Appl Physiol (1985); 2000 Jun; 88(6):1983-8. PubMed ID: 10846009 [TBL] [Abstract][Full Text] [Related]